You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Prostate cancer stage IV

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pharmacogenomics Testing in Directing Optimal Use of Supportive

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +45 more
  • Biospecimen Collection
  • +3 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Feb 3, 2022

Castration-Resistant Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial in Buffalo

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 27, 2022

Prostate Cancer, Stage IV Prostate Cancer Trial in Tampa (Luteinizing Hormone Releasing Hormone, New Hormonal Agent, Docetaxel)

Recruiting
  • Prostate Cancer
  • Stage IV Prostate Cancer
  • Luteinizing Hormone Releasing Hormone
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jun 1, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Detroit,

Active, not recruiting
  • Castration Levels of Testosterone
  • +4 more
  • Detroit, Michigan
  • +1 more
Aug 30, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in San Francisco

Active, not recruiting
  • Castration Levels of Testosterone
  • +6 more
  • Lutetium Lu 177-PSMA-617
  • Pembrolizumab
  • San Francisco, California
    University of California, San Francisco
Apr 11, 2022

Metastatic Malignant Tumor in the Viscera, Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic

Not yet recruiting
  • Metastatic Malignant Neoplasm in the Viscera
  • +4 more
  • Lutetium Lu 177 Dotatate
  • (no location specified)
Jan 25, 2023

Prostate Cancer, Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer Trial in Baltimore, Buffalo (drug, other,

Terminated
  • Prostate Cancer
  • +4 more
  • Baltimore, Maryland
  • +1 more
Sep 30, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • San Francisco, California
    University of California San Francisco
Dec 19, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Biopsy
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2023

Castration-Resistant Prostate Carcinoma, Hormone-Resistant Prostate Cancer, PSA Progression Trial in Portland (drug, other,

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 26, 2022

Genetic Testing for Men With Metastatic Prostate Cancer

Recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Biospecimen Collection
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 9, 2022

Remote Telemonitoring of Patient-Generated Physiologic Health

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +171 more
  • Patient Monitoring
  • Questionnaire Administration
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Atlanta (VLP-encapsulated TLR9 Agonist CMP-001,,

Not yet recruiting
  • Metastatic Prostate Adenocarcinoma
  • Stage IV Prostate Cancer AJCC v8
  • VLP-encapsulated TLR9 Agonist CMP-001,
  • Nivolumab
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 26, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte

Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Oct 7, 2022

Collecting Blood Samples From and Without Cancer to Evaluate

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +61 more
  • Questionnaire Administration
  • Biospecimen Collection
  • (no location specified)
Apr 12, 2022

Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Columbus (Arm I Soy Bread, Arm II Soy-Almond Bread)

Active, not recruiting
  • Recurrent Prostate Cancer
  • Stage IV Prostate Cancer
  • Arm I Soy Bread
  • Arm II Soy-Almond Bread
  • Columbus, Ohio
    The Ohio State University Medical Center
Apr 29, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial (Pharmacotherapy

Not yet recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Pharmacotherapy Discontinuation
  • +3 more
  • (no location specified)
Feb 11, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Adenocarcinoma of the Prostate, Stage IIB Prostate Cancer, Stage III Prostate Cancer Trial in Duarte (biological, procedure,

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • +3 more
  • anti-PSMA monoclonal antibody MDX1201-A488
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma Trial

Recruiting
  • Aggressive Variant Prostate Carcinoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Salt Lake

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Atezolizumab
  • Cabozantinib S-malate
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Mar 11, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • San Francisco, California
    University of California San Francisco
Feb 27, 2022

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Enzalutamide,

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 23, 2022

Fatigue, Metastatic Prostate Carcinoma, Sedentary Lifestyle Trial in Salt Lake City (dietary supplement, behavioral, other)

Recruiting
  • Fatigue
  • +5 more
  • Creatine Monohydrate
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Jan 11, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage IV Prostate

Suspended
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 27, 2022